11/20
07:57 am
pavm
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test [Yahoo! Finance]
Neutral
Report
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test [Yahoo! Finance]
11/18
08:17 am
pavm
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum [Yahoo! Finance]
Medium
Report
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum [Yahoo! Finance]
11/15
02:22 am
pavm
PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring [Yahoo! Finance]
Medium
Report
PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring [Yahoo! Finance]
11/14
03:27 pm
pavm
PAVmed Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
PAVmed Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
11/14
08:01 am
pavm
PAVmed Provides Business Update and Third Quarter 2024 Financial Results
Medium
Report
PAVmed Provides Business Update and Third Quarter 2024 Financial Results
10/31
08:31 am
pavm
PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024
Low
Report
PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024
10/15
07:55 am
pavm
Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test [Yahoo! Finance]
Medium
Report
Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test [Yahoo! Finance]
10/10
07:55 am
pavm
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care [Yahoo! Finance]
High
Report
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care [Yahoo! Finance]
10/10
07:51 am
pavm
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care
Medium
Report
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care
10/8
07:53 am
pavm
Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024 [Yahoo! Finance]
Low
Report
Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024 [Yahoo! Finance]
9/24
08:14 am
pavm
American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test [Yahoo! Finance]
Low
Report
American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test [Yahoo! Finance]
9/17
03:41 am
pavm
Lucid Diagnostics to be deconsolidated from PAVmed's financial statements [Seeking Alpha]
Low
Report
Lucid Diagnostics to be deconsolidated from PAVmed's financial statements [Seeking Alpha]
9/16
04:30 pm
pavm
PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements
Medium
Report
PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements
9/10
08:01 am
pavm
PAVmed Inc. (NASDAQ: PAVM) had its price target lowered by analysts at Ascendiant Capital Markets from $22.00 to $21.00. They now have a "buy" rating on the stock.
High
Report
PAVmed Inc. (NASDAQ: PAVM) had its price target lowered by analysts at Ascendiant Capital Markets from $22.00 to $21.00. They now have a "buy" rating on the stock.